Aug 11, 2026 04:00PM
Aug 3, 2026 08:00AM
Aug 3, 2026 08:00AM
Jul 2, 2026 04:19AM
Jun 25, 2026 04:01PM
Jun 25, 2026 04:01PM
Jun 23, 2026 04:40AM Taysha Gene Therapies (TSHA) PT Raised to $11 at Citizens on REVEAL Data Update
Jun 22, 2026 08:00AM
Jun 22, 2026 08:00AM
May 6, 2026 08:00AM
Apr 27, 2026 05:21PM
Apr 27, 2026 05:21PM
Apr 6, 2026 06:41AM
Mar 25, 2026 07:22AM Taysha Gene Therapies (TSHA) Reiterated at Overweight by Cantor Fitzgerald on Phase 1/2 Data
Mar 19, 2026 01:54PM
Mar 19, 2026 08:00AM
Jan 6, 2026 10:31AM
Jan 6, 2026 08:02AM
Jan 6, 2026 08:00AM
Dec 4, 2025 05:08AM
Nov 5, 2025 05:11AM Taysha Gene Therapies (TSHA) PT Raised to $8 at Citizens on Competitive Advantage
Nov 4, 2025 07:00AM
Oct 20, 2025 04:10PM
Oct 16, 2025 04:02PM
Oct 16, 2025 04:01PM
Oct 9, 2025 08:00AM
Oct 9, 2025 08:00AM
Oct 2, 2025 01:04PM Taysha Gene Therapies (TSHA) PT Raised to $12 at Baird
Oct 2, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 12, 2025 04:11AM
Aug 12, 2025 08:01AM
Jul 11, 2025 06:37AM
Jun 3, 2025 05:26PM
Jun 3, 2025 05:17PM Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program
May 29, 2025 04:12AM
May 28, 2025 04:01PM
May 28, 2025 04:01PM
May 15, 2025 03:33PM
May 15, 2025 08:00AM
Feb 26, 2025 08:00AM
Jan 6, 2025 02:00PM 7 top biotech picks for 2025 according to Wells Fargo
Nov 15, 2024 07:07AM
Nov 13, 2024 04:01PM
Oct 22, 2024 08:00AM
Sep 26, 2024 08:00AM
Aug 12, 2024 08:01AM
Jun 18, 2024 07:30AM
Jun 18, 2024 07:30AM Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
May 14, 2024 04:01PM

328,335 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All